logo
Share SHARE
FONT-SIZE Plus   Neg

Pall Corp. To Buy ForteBio - Quick Facts

Pall Corp. (PLL) said it has signed a definitive merger agreement to buy ForteBio, Inc., a provider of advanced analytical systems that accelerate the discovery and development of biotech drugs. Terms of the deal were not disclosed.

Pall expects the transaction to close by February of 2012. Upon closing, ForteBio will become a wholly-owned subsidiary of Pall Corp. In the short term, the impact to Pall's results of operations will be immaterial.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
British lender Lloyds Banking Group Plc. Friday reported higher profit in its first half, benefited by increased net interest income and margin as well as lower impairment. Looking ahead, the company lifted its net interest margin forecast. Amgen reported an increase in second-quarter profit, driven by sales of arthritis drug Enbrel and osteoporosis treatments Xgeva and Prolia, and improved margins. Both earnings and sales topped Wall Street estimates. Electronic Arts Inc. (EA) on Thursday reported an increase in profit for the first quarter, reflecting continued strong digital revenues, with both earnings and revenues topping Wall Street estimates. However, shares of the company fell over 4 percent, after having detailed a weak outlook. Redwood...
comments powered by Disqus
RELATED NEWS
Trade PLL now with 
Follow RTT